| Dokumendiregister | Ravimiamet |
| Viit | L-1/692-1 |
| Registreeritud | 04.02.2026 |
| Sünkroonitud | 05.02.2026 |
| Liik | Sissetulev kiri |
| Funktsioon | L Ravimite kvaliteedi kontrollimine |
| Sari | L-1 Labori kirjavahetus |
| Toimik | L-1/2026 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | European Directorate for the Quality of Medicines & HealthCare |
| Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
| Vastutaja | Eveli Holst (RA, Peadirektori asetäitja valdkond, Labor) |
| Originaal | Ava uues aknas |
Saatja: BAUTZ Ketty <[email protected]> Saatmisaeg: esmaspäev, 2. veebruar 2026 16:21 Adressaat: Ravimiamet <[email protected]>; Signe Leito <[email protected]> Teema: Request of information - Aripiprazole Generics Programme-
Dear Colleagues, I hope you are doing well!
from EMA regarding the label check questionnaires that have been filled in by the samplers for Aripiprazole.
would still have samples left to get scans of the outer packages. If yes, we would like to receive pictures of the following samples: Aripiprazole Zentiva IT _ Sample J Aripiprazole Sandoz SE _ sample G Aripiprazole Sandoz EL _ sample I Aripiprazole Mylan pharma HR _ Sample E These can be uploaded here: https://act.edqm.eu/s/SRkjRyfw5pxWDwf Many thanks in advance! Ketty
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.